CSPC Pharmaceutical Group Limited (FRA:CVG)

Germany flag Germany · Delayed Price · Currency is EUR
0.9534
-0.0496 (-4.95%)
At close: Oct 17, 2025
-4.95%
Market Cap11.30B
Revenue (ttm)3.09B
Net Income (ttm)458.27M
Shares Outn/a
EPS (ttm)0.04
PE Ratio24.66
Forward PE17.26
Dividend0.03 (2.79%)
Ex-Dividend DateOct 17, 2025
Volume3,283
Average Volume1,442
Open0.9534
Previous Close1.0030
Day's Range0.9534 - 0.9534
52-Week Range0.5158 - 1.2490
Betan/a
RSI46.02
Earnings DateNov 21, 2025

About CSPC Pharmaceutical Group

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally. It operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. The company provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idiopathic Parkinson’s disease; Duomeisu for lymphoma,... [Read more]

Industry Pharmaceutical Preparations
Founded 1992
Employees 21,400
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol CVG
Full Company Profile

Financial Performance

In 2024, CSPC Pharmaceutical Group's revenue was 29.01 billion, a decrease of -7.76% compared to the previous year's 31.45 billion. Earnings were 4.33 billion, a decrease of -26.31%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.